Buchumschlag

A west African ancestry‐associated SNP on 8q24 predicts a positive biopsy in African American men with suspected prostate cancer following PSA screening

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Jian Gu, Lisly Chery, Graciela M. Nogueras González, Chad Huff, Sara Strom, Jeffrey A. Jones, Donald P. Griffith, Steven E. Canfield, Xuemei Wang, Xuelin Huang, Pamela Roberson, Qing H. Meng, Patricia Troncoso, Michael Ittmann, Michael Covinsky, Michael Scheurer, Margarita Irizarry Ramirez, Curtis A. Pettaway
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	The Prostate
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Serum levels of prostate specific antigen, free PSA, [−2]proPSA, fPSA/tPSA ratio, Prostate Health Index, and glycosylation patterns of free PSA in patients with benign prostatic hyperplasia pharmacotherapy
von: Michal Jirásko, et al.
Veröffentlicht: (2024)

Serum Levels of Prostate Specific Antigen, Free PSA, [‐2]proPSA, fPSA/tPSA Ratio, Prostate Health Index, and Glycosylation Patterns of Free PSA in Patients With Benign Prostatic Hyperplasia Pharmacotherapy: Limitations and Future Directions
von: Yitong Weng, et al.
Veröffentlicht: (2025)

Impact of PSA nadir, PSA response and time to PSA nadir on overall survival in real‐world setting of metastatic hormone‐sensitive prostate cancer patients
von: Mike Wenzel, et al.
Veröffentlicht: (2024)

Image‐guided multiparametric magnetic resonance imaging‐transrectal ultrasound fusion biopsy augmented with a sextant versus an extended template random biopsy: Comparison of cancer detection rates, complication and functional outcomes
von: Eric S. Adams, et al.
Veröffentlicht: (2024)

Altered Glycosylation of PSA in Prostate Cancer Tissue
von: Hannu Koistinen, et al.
Veröffentlicht: (2025)

Beyond Baseline: Serial PSA Measurements and Risk Stratification for Prostate Cancer
von: Anwar E. Ahmed, et al.
Veröffentlicht: (2025)

Size and SUVmax define the contribution of nodal metastases to PSA in oligorecurrent prostate cancer
von: Fabian Falkenbach, et al.
Veröffentlicht: (2024)

Outcomes of 10 years of PSA screening for prostate cancer in Norwegian men with Lynch syndrome
von: Eli Marie Grindedal, et al.
Veröffentlicht: (2024)

A Multimarker Model for Prostate Cancer Risk Assessment: Improving Diagnostic Accuracy Beyond PSA
von: Penglu Yang, et al.
Veröffentlicht: (2025)

USPSTF Recommendation Against PSA Screening vs. Stage and Cancer‐Specific Mortality in Localized Prostate Cancer
von: Fabian Falkenbach, et al.
Veröffentlicht: (2025)

PSA Density and Lesion Volume: Key Factors in Avoiding Unnecessary Biopsies for PI‐RADS 3 Lesions
von: Ali Ayranci, et al.
Veröffentlicht: (2024)

LGALS3 cfDNA methylation in seminal fluid as a novel prostate cancer biomarker outperforming PSA
von: Irena Abramovic, et al.
Veröffentlicht: (2024)

Association of Weight Loss and BMI on PSA Levels and Overall Survival in Veterans With Metastatic Castrate‐Resistant Prostate Cancer
von: Nicholas Fedele, et al.
Veröffentlicht: (2025)

Key learnings from concordant systematic biopsies in prostate‐specific membrane antigen positron emission tomography/computed tomography‐guided prostate biopsies: Enhancing targeting accuracy
von: Thomas Büttner, et al.
Veröffentlicht: (2024)

Retrospective analysis of the learning curve in perineal robot‐assisted prostate biopsy
von: Ruth Himmelsbach, et al.
Veröffentlicht: (2024)

The detection rate for prostate cancer in systematic and targeted prostate biopsy in biopsy‐naive patients, according to the localization of the lesion at the mpMRI: A single‐center retrospective observational study
von: Matteo Massanova, et al.
Veröffentlicht: (2024)

Utility of the PROSTest, a Novel Blood‐Based Molecular Assay, Versus PSA for Prostate Cancer Stratification and Detection of Disease
von: Mark Kidd, et al.
Veröffentlicht: (2025)

Cumulative cancer locations on prostate biopsy and active surveillance outcomes in the MRI era
von: Sean A. Fletcher, et al.
Veröffentlicht: (2024)

Prostate Volume and PSA‐Density Estimation by Transabdominal Ultrasound: Prospective Evidence of Comparative Accuracy to MRI and Transrectal Ultrasound in Prostate Cancer Early Diagnostics
von: Liza M. Kurucz, et al.
Veröffentlicht: (2025)

The Prognostic Significance of Radiographic Progression Without PSA Progression in Patients With Metastatic Hormone‐Sensitive Prostate Cancer Treated With First‐Line ARPI Therapy
von: Takeshi Tsutsumi, et al.
Veröffentlicht: (2026)

The Effects of the Blood‐Based S2,3PSA% Test on Prostate Cancer Screening: A Novel Approach to Reduce the Need for MRI and Unnecessary Biopsies
von: Hikari Miura, et al.
Veröffentlicht: (2025)

Diagnostic Performance of the Novel Biomarker S2,3PSA Density for Prostate Biopsy Optimization in Prostate Imaging Reporting and Data System 3–5 Lesions
von: Takanori Tokunaga, et al.
Veröffentlicht: (2025)

Nonantibiotic strategies to decrease the postbiopsy hospitalization rates because of infectious complications after transrectal prostate biopsy
von: Coşkun Bostancı
Veröffentlicht: (2024)

Deep PSA response and extended time‐to‐nadir as robust predictors of survival in Asian patients with de novo metastatic hormone‐sensitive prostate cancer receiving upfront intensified treatment
von: Chris H.‐M. Wong, et al.
Veröffentlicht: (2024)

Predictive Value of PSA Bounce Phenomenon after Stereotactic Body Radiation Therapy in a Large Population of Prostate Cancer Patients Treated By 1.5 T MR Guided Adaptive Technique
von: Andrea Romei, et al.
Veröffentlicht: (2025)

Clinical and histopathological parameters in transrectal ultrasound‐guided biopsies associated with tumor upgrading after radical prostatectomy: A comparative analysis of risk groups
von: Mustafa Ozkaya, et al.
Veröffentlicht: (2024)

Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post‐radiotherapy, and those with de novo metastatic disease
von: Philip Vincent Charlton, et al.
Veröffentlicht: (2024)

Targeting proliferating cell nuclear antigen enhances ionizing radiation‐induced cytotoxicity in prostate cancer cells
von: Shan Lu, et al.
Veröffentlicht: (2024)

PRMT5:MEP50 Are Mediators of Treatment‐Induced Neuroendocrine Differentiation in Prostate Cancer
von: Hye Seung Nam, et al.
Veröffentlicht: (2025)

Impact of Concomitant Hormone Therapy on the Diagnostic Performance of 18F‐Piflufolastat PET/CT in Prostate Cancer Patients: A Sub‐Group Analysis of OSPREY Cohort B
von: Lawrence Saperstein, et al.
Veröffentlicht: (2025)

An orthotopic prostate cancer model for new treatment development using syngeneic or patient‐derived tumors
von: Naz Chaudary, et al.
Veröffentlicht: (2024)

Do Prostate Imaging‐Reporting and Data System (PIRADS) lesions predict holmium laser enucleation of prostate outcomes?
von: Kyle Tsai, et al.
Veröffentlicht: (2024)

Two‐Year Outcomes of Rezūm Therapy in Real‐Life BPH Patients
von: Thibaut Long Depaquit, et al.
Veröffentlicht: (2025)

Pathology of a Canine Model of Localized Prostate Carcinoma
von: Nathan K. Hoggard, et al.
Veröffentlicht: (2025)

Baseline Imaging Derived Factors of Response Following [225Ac]Ac‐J591 Therapy in Metastatic Castration‐Resistant Prostate Cancer: A Lesion Level Analysis
von: Judith Stangl‐Kremser, et al.
Veröffentlicht: (2025)

Incidental Brain Metastases From Prostate Cancer Diagnosed With PSMA PET/CT and MRI: A Case Series and Literature Review
von: Mark Willy L. Mondia, et al.
Veröffentlicht: (2025)

In Vivo Efficacy of a Macrocyclic Peptoid‐Peptide Hybrid That Selectively Modulates the Beta‐Catenin/TCF Interaction to Inhibit Prostate Cancer
von: Justine Habault, et al.
Veröffentlicht: (2025)

Relationship Between Radiation Therapy and Fecal Incontinence in Patients Treated for Localized Prostate Cancer: Results of the French ICONES Study
von: Yazid Belkacemi, et al.
Veröffentlicht: (2025)

Outcome of Subsequent Therapies After 177Lu‐Vipivotide Tetraxetan for Metastatic Castrate‐Resistant Prostate Cancer: A Tertiary Cancer Center Experience
von: Meryam Losee, et al.
Veröffentlicht: (2025)

Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (NRG/RTOG 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following Prostatectomy
von: Emily Chan, et al.
Veröffentlicht: (2025)